161 related articles for article (PubMed ID: 37262305)
21. Mycosis fungoides in young patients: clinical characteristics and outcome.
Crowley JJ; Nikko A; Varghese A; Hoppe RT; Kim YH
J Am Acad Dermatol; 1998 May; 38(5 Pt 1):696-701. PubMed ID: 9591813
[TBL] [Abstract][Full Text] [Related]
22. Optimizing Care and Compliance for the Treatment of Mycosis Fungoides Cutaneous T-Cell Lymphoma With Mechlorethamine Gel.
Benjamin Chase A; Markel K; Tawa MC
Clin J Oncol Nurs; 2015 Dec; 19(6):E131-9. PubMed ID: 26583648
[TBL] [Abstract][Full Text] [Related]
23. Mycosis fungoides and the Sézary syndrome.
Kim YH; Hoppe RT
Semin Oncol; 1999 Jun; 26(3):276-89. PubMed ID: 10375085
[TBL] [Abstract][Full Text] [Related]
24. Chlormethine gel is effective for the treatment of skin lesions in patients with early- and late-stage mycosis fungoides in clinical practice.
Papadavid E; Koumourtzis M; Nikolaou V; Lampadaki K; Marinos L; Patsatsi A; Georgiou E; Dalamaga M; Stratigos A
J Eur Acad Dermatol Venereol; 2022 Oct; 36(10):1751-1757. PubMed ID: 35470483
[TBL] [Abstract][Full Text] [Related]
25. Diagnosis and management of mycosis fungoides.
Galper SL; Smith BD; Wilson LD
Oncology (Williston Park); 2010 May; 24(6):491-501. PubMed ID: 20568590
[TBL] [Abstract][Full Text] [Related]
26. Mechlorethamine Hydrochloride Gel in the Treatment of Mycosis Fungoides-Type Cutaneous T-Cell Lymphoma (MF-CTCL): A Focus on Patient Selection and Special Considerations.
Crimp C; Gangal A; Tarabadkar ES; Shinohara MM
Cancer Manag Res; 2022; 14():3271-3279. PubMed ID: 36444357
[TBL] [Abstract][Full Text] [Related]
27. Interferon alfa-2a maintenance after salvage autologous stem cell transplantation in atypical mycosis fungoides with central nervous system involvement.
Doerschner M; Pekar-Lukacs A; Messerli-Odermatt O; Dommann-Scherrer C; Rütti M; Müller AM; Nair G; Kamarachev J; Kerl K; Beer M; Messerli M; Frauenknecht K; Haralambieva E; Hoetzenecker W; French LE; Guenova E
Br J Dermatol; 2019 Dec; 181(6):1296-1302. PubMed ID: 30565216
[TBL] [Abstract][Full Text] [Related]
28. Time course, clinical pathways, and long-term hazards risk trends of disease progression in patients with classic mycosis fungoides: a multicenter, retrospective follow-up study from the Italian Group of Cutaneous Lymphomas.
Quaglino P; Pimpinelli N; Berti E; Calzavara-Pinton P; Alfonso Lombardo G; Rupoli S; Alaibac M; Bottoni U; Carbone A; Fava P; Fimiani M; Mamusa AM; Titli S; Zinzani PL; Bernengo MG;
Cancer; 2012 Dec; 118(23):5830-9. PubMed ID: 22674564
[TBL] [Abstract][Full Text] [Related]
29. Mycosis Fungoides and Sézary Syndrome: Updates and Review of Current Therapy.
Kamijo H; Miyagaki T
Curr Treat Options Oncol; 2021 Jan; 22(2):10. PubMed ID: 33415447
[TBL] [Abstract][Full Text] [Related]
30. Mycosis fungoides and Sézary syndrome.
Jonak C; Tittes J; Brunner PM; Guenova E
J Dtsch Dermatol Ges; 2021 Sep; 19(9):1307-1334. PubMed ID: 34541796
[TBL] [Abstract][Full Text] [Related]
31. Mycosis fungoides and the Sézary syndrome: pathology, staging, and treatment.
Hoppe RT; Wood GS; Abel EA
Curr Probl Cancer; 1990; 14(6):293-371. PubMed ID: 2245651
[TBL] [Abstract][Full Text] [Related]
32. Phototherapy of mycosis fungoides.
Trautinger F
G Ital Dermatol Venereol; 2017 Dec; 152(6):597-606. PubMed ID: 28845954
[TBL] [Abstract][Full Text] [Related]
33. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.
Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
J Am Acad Dermatol; 2014 Feb; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969
[TBL] [Abstract][Full Text] [Related]
34. Aspects of the treatment of mycosis fungoides. A report from the Scandinavian Mycosis Fungoides Study Group.
Molin L; Thomsen K; Volden G; Groth O; Fischer T; Nordentoft A; Zachariae H
Cutis; 1980 Feb; 25(2):155-7, 160-1. PubMed ID: 6153595
[TBL] [Abstract][Full Text] [Related]
35. Mycosis fungoides: management with topical nitrogen mustard.
Hoppe RT; Abel EA; Deneau DG; Price NM
J Clin Oncol; 1987 Nov; 5(11):1796-803. PubMed ID: 3681368
[TBL] [Abstract][Full Text] [Related]
36. Interventions for mycosis fungoides.
Weberschock T; Strametz R; Lorenz M; Röllig C; Bunch C; Bauer A; Schmitt J
Cochrane Database Syst Rev; 2012 Sep; (9):CD008946. PubMed ID: 22972128
[TBL] [Abstract][Full Text] [Related]
37. European Organisation for Research and Treatment of Cancer consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome - Update 2017.
Trautinger F; Eder J; Assaf C; Bagot M; Cozzio A; Dummer R; Gniadecki R; Klemke CD; Ortiz-Romero PL; Papadavid E; Pimpinelli N; Quaglino P; Ranki A; Scarisbrick J; Stadler R; Väkevä L; Vermeer MH; Whittaker S; Willemze R; Knobler R
Eur J Cancer; 2017 May; 77():57-74. PubMed ID: 28365528
[TBL] [Abstract][Full Text] [Related]
38. Real-life experience with chlormethine gel for early-stage mycosis fungoides with emphasis on types and management of cutaneous side-effects
Prag Naveh H; Amitay-Laish I; Zidan O; Leshem YA; Sherman S; Noyman Y; Taieb J; Didkovsky E; Hodak E
J Dermatolog Treat; 2022 Jun; 33(4):2364-2370. PubMed ID: 34427536
[TBL] [Abstract][Full Text] [Related]
39. Treatment of mycosis fungoides with photochemotherapy (PUVA): long-term follow-up.
Herrmann JJ; Roenigk HH; Hurria A; Kuzel TM; Samuelson E; Rademaker AW; Rosen ST
J Am Acad Dermatol; 1995 Aug; 33(2 Pt 1):234-42. PubMed ID: 7622650
[TBL] [Abstract][Full Text] [Related]
40. [Granulomatous mycosis fungoides histologically simulating cutaneous sarcoidosis].
Maillard H; Croué A; François S; Verret JL
Ann Dermatol Venereol; 1998 Dec; 125(12):912-5. PubMed ID: 9922868
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
